Adaptimmune stock plunges after announcing Nasdaq delisting plans
Clough Charles JR, a person affiliated with the Investment Advisor of Clough Global Opportunities Fund (NYSE:GLO), a $240 million closed-end fund currently offering an impressive 10.7% dividend yield, acquired 8,800 common shares of beneficial interest in the company on September 5, 2025. The shares were purchased at a price of $5.6199, for a total transaction value of $49455. The purchase comes as GLO trades near its 52-week high, having delivered an 18% return year-to-date. Following the transaction, Clough Charles JR directly owns 359244.8229 shares of Clough Global Opportunities Fund . InvestingPro data reveals the fund has maintained dividend payments for 20 consecutive years - discover more dividend insights and financial metrics with a subscription.
In other recent news, Clough Global Opportunities Fund announced amendments to its Amended and Restated By-Laws. Effective June 27, 2025, these changes involve revisions to the provisions governing the forum for adjudication of disputes and clarification of the waiver of jury trial rights. Additionally, updates have been made to allow for additional trustee qualification informational requests. These amendments were detailed in a recent SEC filing, with the full text of the revised bylaws available as an exhibit to the current report on Form 8-K. No further specifics regarding the changes were disclosed in the filing. These developments reflect the fund’s ongoing efforts to update its governance structure.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.